Report Detail
Global Point-of-care Cancer Screening Market Growth (Status and Outlook) 2022-2028
- RnM4484100 |
- 18 August, 2022 |
- Global |
- 101 Pages |
- LPI(LP Information) |
- Other
The global market for Point-of-care Cancer Screening is estimated to increase from US$ million in 2021 to reach US$ million by 2028, exhibiting a CAGR of % during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
The APAC Point-of-care Cancer Screening market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The United States Point-of-care Cancer Screening market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The Europe Point-of-care Cancer Screening market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The China Point-of-care Cancer Screening market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
Global key Point-of-care Cancer Screening players cover Hologic Corporation, Abbott Laboratories, Qiagen N.V., F Hoffmann-La Roche and BD, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
Report Coverage
This latest report provides a deep insight into the global Point-of-care Cancer Screening market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.
This report aims to provide a comprehensive picture of the global Point-of-care Cancer Screening market, with both quantitative and qualitative data, to help readers understand how the Point-of-care Cancer Screening market scenario changed across the globe during the pandemic and Russia-Ukraine War.
The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions.
Market Segmentation:
The study segments the Point-of-care Cancer Screening market and forecasts the market size by Type (Genetic Screening, Image Screening and Others), by Application (Hospital, Clinic and Others,), and region (APAC, Americas, Europe, and Middle East & Africa).
Segmentation by type
Genetic Screening
Image Screening
Others
Segmentation by application
Hospital
Clinic
Others
Segmentation by region
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
Major companies covered
Hologic Corporation
Abbott Laboratories
Qiagen N.V.
F Hoffmann-La Roche
BD
Quest Diagnostics
OncoHealth Corp
Danaher
NOVIGENIX SA
Quidel Corporation
Chapter Introduction
Chapter 1: Scope of Point-of-care Cancer Screening, Research Methodology, etc.
Chapter 2: Executive Summary, global Point-of-care Cancer Screening market size and CAGR, Point-of-care Cancer Screening market size by region, by type, by application, historical data from 2017 to 2022, and forecast to 2028.
Chapter 3: Point-of-care Cancer Screening revenue, global market share, and industry ranking by company, 2017-2022
Chapter 4: Global Point-of-care Cancer Screening revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, revenue segment by country, by type, and application.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global Point-of-care Cancer Screening market size forecast by region, by country, by type, and application
Chapter 13: Comprehensive company profiles of the leading players, including Hologic Corporation, Abbott Laboratories, Qiagen N.V., F Hoffmann-La Roche, BD, Quest Diagnostics, OncoHealth Corp, Danaher and NOVIGENIX SA, etc.
Chapter 14: Research Findings and Conclusion
1 Scope of the Report
- 1.1 Market Introduction
- 1.2 Years Considered
- 1.3 Research Objectives
- 1.4 Market Research Methodology
- 1.5 Research Process and Data Source
- 1.6 Economic Indicators
- 1.7 Currency Considered
2 Executive Summary
- 2.1 World Market Overview
- 2.1.1 Global Point-of-care Cancer Screening Market Size 2017-2028
- 2.1.2 Point-of-care Cancer Screening Market Size CAGR by Region 2017 VS 2022 VS 2028
- 2.2 Point-of-care Cancer Screening Segment by Type
- 2.2.1 Genetic Screening
- 2.2.2 Image Screening
- 2.2.3 Others
- 2.3 Point-of-care Cancer Screening Market Size by Type
- 2.3.1 Point-of-care Cancer Screening Market Size CAGR by Type (2017 VS 2022 VS 2028)
- 2.3.2 Global Point-of-care Cancer Screening Market Size Market Share by Type (2017-2022)
- 2.4 Point-of-care Cancer Screening Segment by Application
- 2.4.1 Hospital
- 2.4.2 Clinic
- 2.4.3 Others
- 2.5 Point-of-care Cancer Screening Market Size by Application
- 2.5.1 Point-of-care Cancer Screening Market Size CAGR by Application (2017 VS 2022 VS 2028)
- 2.5.2 Global Point-of-care Cancer Screening Market Size Market Share by Application (2017-2022)
3 Point-of-care Cancer Screening Market Size by Player
- 3.1 Point-of-care Cancer Screening Market Size Market Share by Players
- 3.1.1 Global Point-of-care Cancer Screening Revenue by Players (2020-2022)
- 3.1.2 Global Point-of-care Cancer Screening Revenue Market Share by Players (2020-2022)
- 3.2 Global Point-of-care Cancer Screening Key Players Head office and Products Offered
- 3.3 Market Concentration Rate Analysis
- 3.3.1 Competition Landscape Analysis
- 3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
- 3.4 New Products and Potential Entrants
- 3.5 Mergers & Acquisitions, Expansion
4 Point-of-care Cancer Screening by Regions
- 4.1 Point-of-care Cancer Screening Market Size by Regions (2017-2022)
- 4.2 Americas Point-of-care Cancer Screening Market Size Growth (2017-2022)
- 4.3 APAC Point-of-care Cancer Screening Market Size Growth (2017-2022)
- 4.4 Europe Point-of-care Cancer Screening Market Size Growth (2017-2022)
- 4.5 Middle East & Africa Point-of-care Cancer Screening Market Size Growth (2017-2022)
5 Americas
- 5.1 Americas Point-of-care Cancer Screening Market Size by Country (2017-2022)
- 5.2 Americas Point-of-care Cancer Screening Market Size by Type (2017-2022)
- 5.3 Americas Point-of-care Cancer Screening Market Size by Application (2017-2022)
- 5.4 United States
- 5.5 Canada
- 5.6 Mexico
- 5.7 Brazil
6 APAC
- 6.1 APAC Point-of-care Cancer Screening Market Size by Region (2017-2022)
- 6.2 APAC Point-of-care Cancer Screening Market Size by Type (2017-2022)
- 6.3 APAC Point-of-care Cancer Screening Market Size by Application (2017-2022)
- 6.4 China
- 6.5 Japan
- 6.6 Korea
- 6.7 Southeast Asia
- 6.8 India
- 6.9 Australia
7 Europe
- 7.1 Europe Point-of-care Cancer Screening by Country (2017-2022)
- 7.2 Europe Point-of-care Cancer Screening Market Size by Type (2017-2022)
- 7.3 Europe Point-of-care Cancer Screening Market Size by Application (2017-2022)
- 7.4 Germany
- 7.5 France
- 7.6 UK
- 7.7 Italy
- 7.8 Russia
8 Middle East & Africa
- 8.1 Middle East & Africa Point-of-care Cancer Screening by Region (2017-2022)
- 8.2 Middle East & Africa Point-of-care Cancer Screening Market Size by Type (2017-2022)
- 8.3 Middle East & Africa Point-of-care Cancer Screening Market Size by Application (2017-2022)
- 8.4 Egypt
- 8.5 South Africa
- 8.6 Israel
- 8.7 Turkey
- 8.8 GCC Countries
9 Market Drivers, Challenges and Trends
- 9.1 Market Drivers & Growth Opportunities
- 9.2 Market Challenges & Risks
- 9.3 Industry Trends
10 Global Point-of-care Cancer Screening Market Forecast
- 10.1 Global Point-of-care Cancer Screening Forecast by Regions (2023-2028)
- 10.1.1 Global Point-of-care Cancer Screening Forecast by Regions (2023-2028)
- 10.1.2 Americas Point-of-care Cancer Screening Forecast
- 10.1.3 APAC Point-of-care Cancer Screening Forecast
- 10.1.4 Europe Point-of-care Cancer Screening Forecast
- 10.1.5 Middle East & Africa Point-of-care Cancer Screening Forecast
- 10.2 Americas Point-of-care Cancer Screening Forecast by Country (2023-2028)
- 10.2.1 United States Point-of-care Cancer Screening Market Forecast
- 10.2.2 Canada Point-of-care Cancer Screening Market Forecast
- 10.2.3 Mexico Point-of-care Cancer Screening Market Forecast
- 10.2.4 Brazil Point-of-care Cancer Screening Market Forecast
- 10.3 APAC Point-of-care Cancer Screening Forecast by Region (2023-2028)
- 10.3.1 China Point-of-care Cancer Screening Market Forecast
- 10.3.2 Japan Point-of-care Cancer Screening Market Forecast
- 10.3.3 Korea Point-of-care Cancer Screening Market Forecast
- 10.3.4 Southeast Asia Point-of-care Cancer Screening Market Forecast
- 10.3.5 India Point-of-care Cancer Screening Market Forecast
- 10.3.6 Australia Point-of-care Cancer Screening Market Forecast
- 10.4 Europe Point-of-care Cancer Screening Forecast by Country (2023-2028)
- 10.4.1 Germany Point-of-care Cancer Screening Market Forecast
- 10.4.2 France Point-of-care Cancer Screening Market Forecast
- 10.4.3 UK Point-of-care Cancer Screening Market Forecast
- 10.4.4 Italy Point-of-care Cancer Screening Market Forecast
- 10.4.5 Russia Point-of-care Cancer Screening Market Forecast
- 10.5 Middle East & Africa Point-of-care Cancer Screening Forecast by Region (2023-2028)
- 10.5.1 Egypt Point-of-care Cancer Screening Market Forecast
- 10.5.2 South Africa Point-of-care Cancer Screening Market Forecast
- 10.5.3 Israel Point-of-care Cancer Screening Market Forecast
- 10.5.4 Turkey Point-of-care Cancer Screening Market Forecast
- 10.5.5 GCC Countries Point-of-care Cancer Screening Market Forecast
- 10.6 Global Point-of-care Cancer Screening Forecast by Type (2023-2028)
- 10.7 Global Point-of-care Cancer Screening Forecast by Application (2023-2028)
11 Key Players Analysis
- 11.1 Hologic Corporation
- 11.1.1 Hologic Corporation Company Information
- 11.1.2 Hologic Corporation Point-of-care Cancer Screening Product Offered
- 11.1.3 Hologic Corporation Point-of-care Cancer Screening Revenue, Gross Margin and Market Share (2020-2022)
- 11.1.4 Hologic Corporation Main Business Overview
- 11.1.5 Hologic Corporation Latest Developments
- 11.2 Abbott Laboratories
- 11.2.1 Abbott Laboratories Company Information
- 11.2.2 Abbott Laboratories Point-of-care Cancer Screening Product Offered
- 11.2.3 Abbott Laboratories Point-of-care Cancer Screening Revenue, Gross Margin and Market Share (2020-2022)
- 11.2.4 Abbott Laboratories Main Business Overview
- 11.2.5 Abbott Laboratories Latest Developments
- 11.3 Qiagen N.V.
- 11.3.1 Qiagen N.V. Company Information
- 11.3.2 Qiagen N.V. Point-of-care Cancer Screening Product Offered
- 11.3.3 Qiagen N.V. Point-of-care Cancer Screening Revenue, Gross Margin and Market Share (2020-2022)
- 11.3.4 Qiagen N.V. Main Business Overview
- 11.3.5 Qiagen N.V. Latest Developments
- 11.4 F Hoffmann-La Roche
- 11.4.1 F Hoffmann-La Roche Company Information
- 11.4.2 F Hoffmann-La Roche Point-of-care Cancer Screening Product Offered
- 11.4.3 F Hoffmann-La Roche Point-of-care Cancer Screening Revenue, Gross Margin and Market Share (2020-2022)
- 11.4.4 F Hoffmann-La Roche Main Business Overview
- 11.4.5 F Hoffmann-La Roche Latest Developments
- 11.5 BD
- 11.5.1 BD Company Information
- 11.5.2 BD Point-of-care Cancer Screening Product Offered
- 11.5.3 BD Point-of-care Cancer Screening Revenue, Gross Margin and Market Share (2020-2022)
- 11.5.4 BD Main Business Overview
- 11.5.5 BD Latest Developments
- 11.6 Quest Diagnostics
- 11.6.1 Quest Diagnostics Company Information
- 11.6.2 Quest Diagnostics Point-of-care Cancer Screening Product Offered
- 11.6.3 Quest Diagnostics Point-of-care Cancer Screening Revenue, Gross Margin and Market Share (2020-2022)
- 11.6.4 Quest Diagnostics Main Business Overview
- 11.6.5 Quest Diagnostics Latest Developments
- 11.7 OncoHealth Corp
- 11.7.1 OncoHealth Corp Company Information
- 11.7.2 OncoHealth Corp Point-of-care Cancer Screening Product Offered
- 11.7.3 OncoHealth Corp Point-of-care Cancer Screening Revenue, Gross Margin and Market Share (2020-2022)
- 11.7.4 OncoHealth Corp Main Business Overview
- 11.7.5 OncoHealth Corp Latest Developments
- 11.8 Danaher
- 11.8.1 Danaher Company Information
- 11.8.2 Danaher Point-of-care Cancer Screening Product Offered
- 11.8.3 Danaher Point-of-care Cancer Screening Revenue, Gross Margin and Market Share (2020-2022)
- 11.8.4 Danaher Main Business Overview
- 11.8.5 Danaher Latest Developments
- 11.9 NOVIGENIX SA
- 11.9.1 NOVIGENIX SA Company Information
- 11.9.2 NOVIGENIX SA Point-of-care Cancer Screening Product Offered
- 11.9.3 NOVIGENIX SA Point-of-care Cancer Screening Revenue, Gross Margin and Market Share (2020-2022)
- 11.9.4 NOVIGENIX SA Main Business Overview
- 11.9.5 NOVIGENIX SA Latest Developments
- 11.10 Quidel Corporation
- 11.10.1 Quidel Corporation Company Information
- 11.10.2 Quidel Corporation Point-of-care Cancer Screening Product Offered
- 11.10.3 Quidel Corporation Point-of-care Cancer Screening Revenue, Gross Margin and Market Share (2020-2022)
- 11.10.4 Quidel Corporation Main Business Overview
- 11.10.5 Quidel Corporation Latest Developments
12 Research Findings and Conclusion
Summary:
Get latest Market Research Reports on Point-of-care Cancer Screening. Industry analysis & Market Report on Point-of-care Cancer Screening is a syndicated market report, published as Global Point-of-care Cancer Screening Market Growth (Status and Outlook) 2022-2028. It is complete Research Study and Industry Analysis of Point-of-care Cancer Screening market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
